Rezultati pretraživanja
  1. After finding success in gene therapy, Catalent is moving into cellular medicines.

  2. 31. sij

    explains that the primary cause of , , , and other chronic diseases is a chronic of , , , and other specific .

  3. 21. sij

    Growing number of physicians seek evidence-based as investment drives demand for physician training like courses & workforce development. GID leads as example w/ data 'yrs ahead of others' acc to

  4. 17. sij
  5. 15. sij

    ASX & NASDAQ global leader in allogeneic cellular medicines for inflammatory diseases is pushing 52 week highs up over 100% during that period. On the brink of FDA approval and some massive phase 3 readouts in coming months 👀

    Prikaži ovu nit
  6. 15. sij

    Leaders from & Regenerative Outcomes came together for 1st time to discuss advancing . Read for shared views on FDA compliance, workforce development & more.

  7. 3. sij
  8. 10. pro 2019.
  9. 7. stu 2019.

    The field is on fire and we're proud to be one of the organizations leading the charge! Yesterday, Executive Director Jilian Abramson and President Gerard Malanga presented to a group of experts meeting with the common goal of advancing .

  10. 3. lis 2019.

    The approach defines an optimum daily intake of specific as a basic measure for maintaining , and the effective, safe control of many pathological conditions.

  11. 4. srp 2019.
  12. 17. lip 2019.

    Have an issue... let’s make it better. Call us and feel great again! 215.508.5555 ext1 @ Regen America Centers for Regenerative Medicine

  13. 11. sij 2019.
  14. 3. sij 2019.

    Good to be back in . I’ve missed you. New client kick-off today! alternative is almost here.

  15. 16. stu 2018.
  16. 6. srp 2018.

    incorporates a wide range of biological processes from structure and function of biomolecules to cell physiology to understand the abnormal biological function at the cellular level.

  17. 1. ožu 2018.
  18. 15. velj 2018.

    This morning co-founders and joined on the set of to discuss their latest venture in .

  19. 24. kol 2017.

    An impressive Board of Directors, a groundbreaking team!

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.